YOLFTbeta
30

Guanhao Biotech Co Ltd

300238 · SHE · Healthcare / Biotechnology

10.34CNY-0.29 (-2.73%)

Price History

Full chart

Market Stats

Previous Close10.63
Open10.63
Day Range10.33 – 10.65
52-Week Range10.19 – 18.00
Volume2.66M
Market Cap3.28B
P/E (TTM)199.17
Forward P/E5000.00
EPS0.06
Dividend Yield0.00%
Beta0.18
50-Day Avg11.52
200-Day Avg13.57

About

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Feng Zhao
  • Employees535
  • HeadquartersNo. 12 Yuyan Road, Guangzhou, China, 510530, China
  • Websitehttps://www.guanhaobio.com

Leadership

  • Mr. Feng ZhaoVice Chairman & GM · b. 1978
  • Ms. Junhui Zhao CPAExecutive VP & CFO · b. 1976
  • Mr. Xu QingrongDeputy GM & Secretary · b. 1981
  • Mr. Zhen YouDeputy General Manager · b. 1981
  • Mr. Weikun ZhangDeputy General Manager · b. 1986
  • Mr. Huaixin HouDeputy General Manager · b. 1968
  • Prof. Guofeng XuChief Technology Officer

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue22.38M35.19M65.57M102.62M128.51M147.02M168.50M190.36M226.17M312.79M460.60M458.46M437.89M436.96M488.98M377.29M404.18M377.48M383.42M
Growth (%)-+57.28%+86.32%+56.50%+25.23%+14.40%+14.61%+12.97%+18.82%+38.30%+47.25%-0.46%-4.49%-0.21%+11.91%-22.84%+7.13%-6.60%+1.57%
Cost of Revenue1.41M1.96M3.91M7.29M7.89M10.41M17.70M22.04M41.48M68.96M124.77M127.02M145.00M125.09M125.38M159.60M88.26M78.83M104.65M
Gross Profit20.97M33.23M61.66M95.33M120.62M136.61M150.81M168.31M184.70M243.83M335.83M331.44M292.89M311.87M363.60M217.69M315.92M298.65M278.77M
Gross Margin93.71%94.42%94.04%92.90%93.86%92.92%89.50%88.42%81.66%77.95%72.91%72.29%66.89%71.37%74.36%57.70%78.16%79.12%72.71%
Operating Expense17.85M28.56M50.77M61.42M81.67M103.44M112.40M117.21M123.02M201.60M288.91M288.00M779.74M266.90M282.04M509.73M281.93M270.41M249.45M
Operating Income3.12M4.67M10.89M33.91M38.95M33.17M38.40M51.10M61.67M42.23M46.92M43.44M-486.86M44.96M81.56M-292.04M33.99M28.24M29.32M
Operating Margin13.93%13.26%16.61%33.05%30.31%22.56%22.79%26.84%27.27%13.50%10.19%9.48%-111.18%10.29%16.68%-77.41%8.41%7.48%7.65%
EBITDA3.03M8.99M17.11M40.15M42.08M33.75M62.67M77.33M97.32M95.72M91.35M100.82M-437.89M87.64M117.99M-263.67M56.93M50.26M55.48M
EBITDA Margin13.56%25.54%26.09%39.13%32.74%22.96%37.19%40.63%43.03%30.60%19.83%21.99%-100.00%20.06%24.13%-69.89%14.08%13.32%14.47%
Net Income2.81M7.09M14.42M32.34M40.42M37.03M40.57M50.10M63.37M56.96M45.52M45.75M-465.33M46.59M73.69M-307.82M31.01M27.42M24.35M
Net Income Margin12.56%20.16%21.99%31.52%31.45%25.19%24.08%26.32%28.02%18.21%9.88%9.98%-106.27%10.66%15.07%-81.59%7.67%7.26%6.35%
R&D-13.49M24.64M17.69M16.09M14.85M24.69M25.59M17.32M15.53M49.91M42.96M69.95M34.25M46.62M50.52M44.50M36.16M37.73M
R&D as % of Total Revenue-38.32%37.58%17.24%12.52%10.10%14.65%13.44%7.66%4.96%10.84%9.37%15.97%7.84%9.53%13.39%11.01%9.58%9.84%
Interest Expense23.10K147.06K17.16K29.73K43.36K39.03K41.48K48.66K1.03M9.54M11.53M22.80M15.78M14.58M9.59M5.40M3.33M1.91M4.22M
Interest Expense % of Total Revenue0.10%0.42%0.03%0.03%0.03%0.03%0.02%0.03%0.45%3.05%2.50%4.97%3.60%3.34%1.96%1.43%0.82%0.50%1.10%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets40.70M61.82M122.30M236.02M496.06M541.99M572.52M619.54M807.02M1.69B1.72B1.64B1.15B1.13B1.10B670.21M678.59M754.40M806.53M
Total Liabilities20.03M24.81M45.34M91.03M63.27M87.88M74.36M87.92M186.41M230.93M505.25M483.57M445.21M418.07M350.58M239.33M222.33M286.81M300.50M
Total Equity20.67M37.01M76.95M144.99M432.79M454.11M498.16M531.61M581.04M1.39B1.17B1.15B711.41M730.27M783.92M485.31M520.59M542.36M570.07M
Cash21.22M12.07M31.55M59.75M272.14M234.43M235.75M226.86M288.43M325.20M278.28M104.73M139.57M156.20M159.31M126.28M105.14M106.78M160.60M
Total Debt---9.00M-222.50K169.10K115.70K100.00M80.00M324.60M297.60M268.01M207.64M151.38M79.06M48.59M102.63M126.93M
Net Debt-21.22M-12.07M-31.55M-50.75M-272.14M-234.21M-235.58M-226.74M-188.43M-245.20M46.32M192.87M128.44M51.44M-7.93M-47.22M-50.47M-4.15M-33.68M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.73M4.80M5.55M33.76M35.45M49.12M41.49M65.45M67.87M30.68M19.22M32.28M92.55M103.84M122.39M70.98M54.15M49.55M71.47M
Investing Cash Flow-6.08M-23.48M-33.83M-33.30M-61.28M-71.45M-42.69M-65.75M-127.93M-433.05M-316.22M2.53M-1.05M-12.61M2.70M-40.02M-51.11M-84.95M-36.19M
Financing Cash Flow22.28M9.29M47.70M28.54M238.26M-15.38M2.52M-8.59M121.59M435.18M251.14M-213.54M-58.19M-74.42M-121.78M-70.65M-27.32M43.59M21.02M
Capital Expenditure6.08M23.33M34.08M33.30M61.29M71.45M42.69M29.41M19.18M64.18M31.88M33.65M6.32M2.90M4.71M41.17M53.92M76.20M38.17M
Free Cash Flow-4.35M-18.53M-28.53M450.62K-25.83M-22.33M-1.21M36.04M48.69M-33.50M-12.66M-1.37M86.22M100.94M117.68M29.81M231.14K-26.65M33.30M
Dividends Paid34.42K147.06K---15.28M12.22M12.34M13.10M6.95M25.10M29.30M14.92M14.17M6.97M3.68M1.21M2.46M3.67M
FCF to OCF-251.76%-385.83%-513.87%1.33%-72.86%-45.45%-2.90%55.06%71.74%-109.17%-65.89%-4.25%93.17%97.21%96.15%41.99%0.43%-53.78%46.60%
Dividend Paid to FCF-0.79%-0.79%----68.41%-1014.01%34.25%26.90%-20.74%-198.24%-2136.18%17.31%14.04%5.92%12.34%521.47%-9.25%11.02%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Sep 3, 2014Oct 24, 2014Feb 11, 2015Apr 24, 2015Aug 26, 2015Oct 12, 2015Mar 9, 2016Apr 22, 2016Aug 5, 2016Oct 24, 2016Feb 27, 2017Apr 19, 2017Jul 26, 2017Oct 20, 2017Apr 26, 2018Aug 28, 2018Oct 19, 2018Apr 30, 2019Aug 30, 2019Nov 30, 2019Apr 24, 2020Jul 20, 2020Oct 26, 2020Mar 8, 2021Apr 9, 2021Aug 25, 2021Oct 14, 2021Apr 14, 2022Aug 25, 2022Oct 27, 2022Apr 19, 2023Aug 22, 2023Oct 24, 2023Mar 5, 2024Apr 25, 2024Aug 28, 2024Oct 28, 2024Mar 5, 2025Apr 22, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------
EPS Actual0.040.090.050.030.030.040.030.030.040.070.030.030.050.090.040.030.060.130.030.030.060.130.040.050.090.03-0.010.070.04-0.000.02-1.810.060.040.040.070.080.080.08-1.000.05-0.290.030.04-0.040.050.020.03-0.000.060.020.02-0.010.040.01
Surprise-------------------------------------------------------
Timing------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap3.28B
Enterprise Value3.31B
Trailing P/E199.17
Forward P/E5000.00
PEG Ratio0.00
Price / Sales9.08
Price / Book5.70
EPS0.06
Book Value2.20
Revenue (TTM)361.40M
Gross Profit (TTM)274.37M
EBITDA37.87M
Profit Margin4.75%
Operating Margin1.56%
Return on Equity1.20%
Return on Assets1.41%
Shares Outstanding274.70M
Shares Float202.03M
Beta0.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
0.05Jun 20, 2018
20171×
0.08May 16, 2017
20151×
0.05Apr 16, 2015
20141×
0.05May 16, 2014
20131×
0.05May 16, 2013
20121×
0.03May 7, 2012

Stock Splits

  • Apr 16, 201520:10
  • May 7, 201220:10